3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
von Hippel-Lindau Disease
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lung Neoplasms
1
Kidney Neoplasms
1
Hodgkin Disease
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Medullary
1
Breast Neoplasms
1
Adenocarcinoma, Follicular
1
Interventions
fludarabine phosphate
19
Whole-Body Irradiation
15
Peripheral Blood Stem Cell Transplantation
15
Mycophenolic Acid
15
Tacrolimus
12
Cyclosporine
11
Cyclophosphamide
11
Antilymphocyte Serum
11
Busulfan
10
Rituximab
7
Methotrexate
7
Etoposide
6
Melphalan
5
Flow Cytometry
5
Radiotherapy
4
Panobinostat
4
Lenalidomide
4
Filgrastim
4
Everolimus
4
Dexamethasone
4
Calcium Dobesilate
4
thymoglobulin
3
romidepsin
3
pembrolizumab
3
mogamulizumab
3
fludarabine
3
Therapeutics
3
Sirolimus
3
In Situ Hybridization, Fluorescence
3
Immunohistochemistry
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sezary Syndrome
×
tanespimycin
×
Clear all
No trials found.